Feature

Podcasts driving a revolution in rheumatology medical education

December 6, 2019
When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the…

In the Journals

ILD affects systemic sclerosis outcomes

December 4, 2019
The presence of interstitial lung disease at systemic sclerosis diagnosis appears to affect disease outcomes, with data indicating that even mild…

Education Lab

Ace the Case: A 76-Year-Old Female With White Discoloration of Fingers

Healio Rheumatology, November 2019
Learning Objective: Upon successful completion of this educational activity, participants will be better able to assess and treat patients with…

Meeting News

Guideline-based registry shows value for studying systemic sclerosis

November 11, 2019
Guideline-based registries designed by physicians, patients and information technology experts demonstrate high data completion and value, with the…

In the Journals

Opportunistic infection risk highest for patients with polymyositis, dermatomyositis

October 30, 2019
Among systemic rheumatic diseases, the risk for opportunistic infection is highest among patients with polymyositis or dermatomyositis, followed by…

In the JournalsPerspective

Cancer, infection risk higher among patients treated with IL inhibitors

October 29, 2019
Rheumatology patients treated with interleukin inhibitors have an increased risk for serious infections, opportunistic infections and cancer…

Feature

Scleroderma Foundation Gives Voice to 'Overlooked' Disease

October 25, 2019
In a world where potentially fatal, high-profile diseases like breast cancer and diabetes devour resources and media attention, organizations like…

Meeting News

Macitentan safe, effective for PAH associated with systemic sclerosis

October 22, 2019
NEW ORLEANS — New real-world data demonstrate safety and effectiveness of macitentan for the treatment of pulmonary arterial hypertension…

In the Journals

Systemic sclerosis more than doubles risk for cancer

October 15, 2019
Patients with systemic sclerosis carry a more than twofold increased risk for cancer — particularly lung, early breast and early melanoma…

Meeting News

Nintedanib approval provides 'exciting news' for other CTD-associated ILD

October 1, 2019
SAN DIEGO — A recent FDA approval for systemic sclerosis-associated interstitial lung diseases may portend a new hope for clinicians managing…

Meeting News

Early diagnosis in systemic sclerosis key to limiting comorbidities

September 29, 2019
SAN DIEGO — Early screening and early diagnosis are critical to managing systemic sclerosis, according to a presentation at the 2019 Congress…

Feature

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

September 20, 2019
By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits…

In the Journals

Patient-reported symptoms linked to disease activity changes in SSc

September 10, 2019
Patient-reported symptoms are associated with clinically impactful changes in systemic sclerosis disease activity, according to findings published in…

FDA News

FDA approves nintedanib for systemic sclerosis-associated ILD

September 6, 2019
The FDA has approved nintedanib capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with…

Meeting News

In scleroderma, rheumatology nurses essential to treat the ‘whole patient’

August 12, 2019
ORLANDO — Rheumatology nurses are necessary for helping to care for “the whole patient” with scleroderma, including its various…

FDA News

FDA panel supports approval of nintedanib for systemic sclerosis-associated ILD

July 26, 2019
The FDA Arthritis Advisory Committee voted 10-7 to recommend approval of nintedanib for treatment of systemic sclerosis-associated interstitial lung…

In the Journals

Less than 40% of patients with SSc treated with physical therapy

June 27, 2019
An analysis of a large German registry found that 37% of patients with systemic sclerosis receive physical therapy, according to recent findings in…

Feature

Social media opens new avenue to advocacy in rheumatology

June 21, 2019
Political activism is more accessible than ever thanks to the amplification offered by social media, and rheumatologists can use social media —…

Q&A With Healio Rheumatology

Speaking the Language: Health care execs join United Rheumatology to advocate for independent practice

May 24, 2019
In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web…

Meeting News

Stem cells likely 'way of the future' in systemic sclerosis treatment

May 23, 2019
CLEVELAND — Autologous hematopoietic stem cell transplantation, which has recently emerged as a potentially effective option for select…